Improving Delivery of Healthcare Services for Polysubstance Use
The Research Need
The nation’s opioid crisis has evolved significantly, now reflecting use of drug combinations, potent synthetic opioids, and stimulants. Toward finding durable solutions to the opioid crisis, research approaches must recognize these shifting patterns of use.
About the Program
This program will support research to expand what we know about drug combinations as well as how to prevent and treat addiction and overdose resulting from these new use trends. An important focus will be research to better understand the causes, patterns, and implications of polysubstance use. That includes which substances are commonly used together, how polysubstance use affects individuals taking medications for pain or for treatment of opioid use disorder, and what role polysubstance use plays in overdose deaths and suicide.
This research will explore health outcomes of individuals who use drug combinations, particularly those who are treated for one or more substance use disorders. This research will consider the perspectives not only of patients, but also of clinicians, payors, and policy makers.
The program will support clinical trials to study service delivery and treatment approaches for people who use multiple substances at the same time, with a particular focus on opioids and/or stimulants. This research will pave the way for larger clinical trials by developing research methods and interventions.
Through the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, NIH has awarded research grants and administrative supplements to increase understanding of, and enhance service delivery for, polysubstance use. These awards are administered by multiple NIH Institutes and Centers.
Research examples supported by this program include:
- Determining the extent of polysubstance use
- Clarifying the role of synthetic opioids and other drugs in the transition to polysubstance use
- Identifying appropriate outcome measures for polysubstance treatment responses and recovery
- Developing and testing the feasibility of sequential treatment approaches
- Friends Research Institute, Inc. – Maryland
- Johns Hopkins University – Maryland
- New York University School of Medicine – New York
- Oregon Social Learning Center – Oregon
- RBHS-Robert Wood Johnson Medical School – New Jersey
- University of Maryland, College Park – Maryland
- University of Michigan – Michigan
- University of Washington – Washington
- Yale University – Connecticut
Participating NIH Institutes, Centers, and Offices
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute on Aging (NIA)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
View Other Research Programs in This Focus Area
- Behavioral Research to Improve Medication-Based Treatment (BRIM)
- Enhancing the National Drug Abuse Treatment Clinical Trials Network to Address Opioids
- Harm Reduction Approaches to Reduce Overdose Death
- HEALing Communities Study
- Justice Community Opioid Innovation Network (JCOIN)
- Recovery Research Networks
- The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE)